Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

October 20, 2021
Preprint
Open Access

Metastatic profiling of HER2-positive breast cancer cell lines in xenograft models

BioRxiv : the Preprint Server for Biology
Y. HanJun Nakayama
October 16, 2021

rs6426881 in the 3'-UTR of PBX1 is involved in breast and gastric cancers via altering the binding potential of miR-522-3p.

Molecular Biology Reports
Maryam MohammadiAlireza Tarang
October 16, 2021
Comment / Editorial

Correspondence to "Locoregional therapy in de novo metastatic breast cancer: Systematic review and meta-analysis, written by Reinhorn D et al. In The Breast Journal 58 (2021) 173-181".

The Breast : Official Journal of the European Society of Mastology
Atilla SoranBreast Health Working Group International.
October 16, 2021
Review
Open Access

Prognostic impact of tertiary lymphoid structures in breast cancer prognosis: a systematic review and meta-analysis.

Cancer Cell International
Na-Na ZhangYi Lv
October 16, 2021

Clinicopathological Characteristics and Prognosis of Squamous Cell Carcinoma of the Breast: A Population-Based Analysis.

Cancer Control : Journal of the Moffitt Cancer Center
Yiqun HanBinghe Xu
October 16, 2021

Mannose-modified liposome designed for epitope peptide drug delivery in cancer immunotherapy.

International Immunopharmacology
Jiankun YuMinjie Wei
October 16, 2021
Review

The molecular mechanisms and therapeutic potential of EZH2 in breast cancer.

Life Sciences
Sara AdibfarFarhad Jadidi-Niaragh
October 16, 2021

Expression of N-Terminal-Deficient E-Cadherin Protein in Invasive Lobular Carcinoma of the Breast.

The American Journal of Surgical Pathology
Haruna YasuiTakashi Sugino
October 16, 2021

Non-18F-FDG-Avid Intrahepatic Metastasis of Breast Cancer Revealed by 68Ga-FAPI PET/CT.

Clinical Nuclear Medicine
Qixin WangYue Chen
October 15, 2021
Preprint
Open Access

A Novel 3D Co-culture Platform for Integrating Tissue Interfaces for Tumor Growth, Migration and Therapeutic Sensitivity: PP-3D-S

BioRxiv : the Preprint Server for Biology
M. M. GarakaniAbdellah Ajji
October 15, 2021
Case Report

BRCA1 Reversion Mutation Confers Resistance to Olaparib and Camrelizumab in a Patient with Breast Cancer Liver Metastasis.

Journal of breast cancer
Jia-Ni PanWen-Ming Cao
October 15, 2021

[Effect of free deep inferior epigastric artery perforator flap transplantation in breast shaping of two-staged breast reconstruction with vertical scar].

Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
Dajiang SongZhiyuan Wang
October 15, 2021

Ethmoïdal metastasis as a first presentation of breast cancer.

International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics
Naourez KolsiJamel Koubaa
October 15, 2021
Review

The lymphatic system and sentinel lymph nodes: conduit for cancer metastasis.

Clinical & Experimental Metastasis
Stanley P LeongAmanda W Lund

Sign up to follow this feed and discover related papers.

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Anthracycline Sensitivity & Chromatin (Keystone)

Anthracyclines are used in the treatment of cancer and work by inhibiting topoisomerase II (TOP2). Recent evidence suggests that because DNA accessibility is crucial for TOP2 binding, chromatin regulatory genes should predict anthracycline response. Find the latest research on anthracycline sensitivity and chromatin regulators in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

© 2021 Meta ULC. All rights reserved
/feed-previews/breast-invasive-carcinoma-keystone/7b7e0d27-792e-458e-bf22-1b7ea8eb5ad8